Related content

Response to nab-paclitaxel and nedaplatin in a heavily-metastatic thymic carcinoma: A case report

By      

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1715-1718

Spandidos Publications

Access to resources Recommend Favorite

Successful chemotherapy with carboplatin and nab-paclitaxel for thymic large cell neuroendocrine carcinoma: A case report

By                    

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3519-3522

Spandidos Publications

Access to resources Recommend Favorite

Successful Treatment with Nab-Paclitaxel and Gemcitabine after FOLFIRINOX Failure in a Patient with Metastasized Pancreatic Adenocarcinoma

By  

Onkologie, Vol. 36, Iss. 12, 2013-11 ,pp. : 763-765

Karger

Access to resources Recommend Favorite

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer

By        

International Journal of Oncology, Vol. 43, Iss. 5, 2013-01 ,pp. : 1627-1635

Spandidos Publications

Access to resources Recommend Favorite

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

By Lobo Christopher   Lopes Gilberto   Baez Odalys   Castrellon Aurelio   Ferrell Annapoorna   Higgins Connie   Hurley Erin   Hurley Judith   Reis Isildinha   Richman Stephen   Seo Pearl   Silva Orlando   Slingerland Joyce   Tukia Keleni   Welsh Catherine   Glück Stefan  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 427-435

Springer Publishing Company

Access to resources Recommend Favorite